ATRA Crosses Above Average Analyst Target
8/5 12:58
In recent trading, shares of Atara Biotherapeutics Inc (Symbol: ATRA) have crossed above the average analyst 12-month target price of $9.33, changing hands for $9.93/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade...